Team:Braunschweig/Notebook
From 2013.igem.org
(Difference between revisions)
Line 16: | Line 16: | ||
margin-top: 100px; | margin-top: 100px; | ||
} | } | ||
+ | |||
/* Laborjournal Weeks */ | /* Laborjournal Weeks */ | ||
Line 80: | Line 81: | ||
<h2><a href="#Week1">Week 1: May 19 - May 26, 2013</a></h2> | <h2><a href="#Week1">Week 1: May 19 - May 26, 2013</a></h2> | ||
<p style=" margin-left:5px; margin-right:5px; margin-bottom:0px;">We set up our labspace and started some preparatory work.</p> | <p style=" margin-left:5px; margin-right:5px; margin-bottom:0px;">We set up our labspace and started some preparatory work.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; padding:0px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, May 21, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; padding:0px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, May 21, 2013</p> | ||
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px; padding:0px;"> <img alt="May21" src="https://static.igem.org/mediawiki/2013/a/a3/Braunschweig_Lab_Journal_May_21.jpg" width="400" align="right" vspace="0" hspace="20"/> | <p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px; padding:0px;"> <img alt="May21" src="https://static.igem.org/mediawiki/2013/a/a3/Braunschweig_Lab_Journal_May_21.jpg" width="400" align="right" vspace="0" hspace="20"/> | ||
We finally moved in our lab. A bit of dust here and some rubbish to dispose there, but after a few hours of combined strength our lab was ready to go. Wet experiments can begin!</p> | We finally moved in our lab. A bit of dust here and some rubbish to dispose there, but after a few hours of combined strength our lab was ready to go. Wet experiments can begin!</p> | ||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px";>Thursday, May 23, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px";>Thursday, May 23, 2013</p> | ||
Line 90: | Line 96: | ||
<b>Investigators: Kevin, Kerstin, Laura</b><br> | <b>Investigators: Kevin, Kerstin, Laura</b><br> | ||
We prepared some chemically competent XL1 blue <i>E. Coli</i> cells for all the transformations we are going to have to do during the project.</p> | We prepared some chemically competent XL1 blue <i>E. Coli</i> cells for all the transformations we are going to have to do during the project.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px">Friday, May 24, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px">Friday, May 24, 2013</p> | ||
Line 97: | Line 106: | ||
Today we transformed our freshly prepared competent cells for test purposes. We used the plasmids pUC 18 and pUC19 to calculate the transformation efficiency. 100 pg of DNA were used for each transformation with 50 µl cells. | Today we transformed our freshly prepared competent cells for test purposes. We used the plasmids pUC 18 and pUC19 to calculate the transformation efficiency. 100 pg of DNA were used for each transformation with 50 µl cells. | ||
Additionally, competent cells were plated on Ampicillin, Kanamycin and Chloramphenicol to ensure that the strain is not carrying any corresponding resistances. The plates were incubated at 37 °C overnight.</p> | Additionally, competent cells were plated on Ampicillin, Kanamycin and Chloramphenicol to ensure that the strain is not carrying any corresponding resistances. The plates were incubated at 37 °C overnight.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
Line 122: | Line 134: | ||
<b>Investigators: All</b><br> | <b>Investigators: All</b><br> | ||
Today we developed our cloning strategy. Details can be found in the <a href="https://2013.igem.org/Team:Braunschweig/Project/Appoach">Approach section</a><br> </p> | Today we developed our cloning strategy. Details can be found in the <a href="https://2013.igem.org/Team:Braunschweig/Project/Appoach">Approach section</a><br> </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, May 28, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, May 28, 2013</p> | ||
Line 130: | Line 145: | ||
We resuspended the DNA of 19 BioBricks, measured the DNA concentrations via NanoDrop and transformed each BioBrick. This is the full list of BioBricks we planned on using in our project:<br> | We resuspended the DNA of 19 BioBricks, measured the DNA concentrations via NanoDrop and transformed each BioBrick. This is the full list of BioBricks we planned on using in our project:<br> | ||
<img alt="May28" src="https://static.igem.org/mediawiki/2013/a/ac/Braunschweig_Labjournal_May28_new.png" width="800" vspace="0" hspace="20" position="center"/> | <img alt="May28" src="https://static.igem.org/mediawiki/2013/a/ac/Braunschweig_Labjournal_May28_new.png" width="800" vspace="0" hspace="20" position="center"/> | ||
- | |||
</p> | </p> | ||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, May 29, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, May 29, 2013</p> | ||
Line 149: | Line 164: | ||
We repeated the transformation of all the above listed BioBricks. However, we noticed that many of these parts had an <i>ampR</i> backbone.</p> | We repeated the transformation of all the above listed BioBricks. However, we noticed that many of these parts had an <i>ampR</i> backbone.</p> | ||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, May 30, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, May 30, 2013</p> | ||
Line 159: | Line 176: | ||
J23100<br> | J23100<br> | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
Line 175: | Line 195: | ||
<h2><a href="#Week3">Week 3: June 2 - June 8, 2013</a></h2> | <h2><a href="#Week3">Week 3: June 2 - June 8, 2013</a></h2> | ||
<p style=" margin-left:5px; margin-right:5px;">This week we successfully cloned and transformed some of our first combination Bricks. We also managed to obtain some BioBricks that could not be transformed via Phusion-PCR directly from resuspended DNA.</p> | <p style=" margin-left:5px; margin-right:5px;">This week we successfully cloned and transformed some of our first combination Bricks. We also managed to obtain some BioBricks that could not be transformed via Phusion-PCR directly from resuspended DNA.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Sunday, June 2, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Sunday, June 2, 2013</p> | ||
Line 183: | Line 206: | ||
We prepared 5 mL liquid cultures of Bricks B0012, B0032, B1009, C0060, C0061, C0062, C0070, C0071, C0078, C0079, E0240, E0430, J06702, R0062, R0071 in order to miniprep them the next day.</p> | We prepared 5 mL liquid cultures of Bricks B0012, B0032, B1009, C0060, C0061, C0062, C0070, C0071, C0078, C0079, E0240, E0430, J06702, R0062, R0071 in order to miniprep them the next day.</p> | ||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, June 3, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, June 3, 2013</p> | ||
Line 192: | Line 217: | ||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, June 4, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, June 4, 2013</p> | ||
Line 201: | Line 227: | ||
<img alt="June4" src="https://static.igem.org/mediawiki/2013/f/fd/Braunschweig_Labjournal_June4.png" width="600" align="center" vspace="0" hspace="20"/> | <img alt="June4" src="https://static.igem.org/mediawiki/2013/f/fd/Braunschweig_Labjournal_June4.png" width="600" align="center" vspace="0" hspace="20"/> | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
+ | |||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, June 5, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, June 5, 2013</p> | ||
Line 210: | Line 240: | ||
A gel electrophoresis was conducted with the freshly acquired PCR products of B0015, J23100 and J23106 as well as C0060, C0061, C0070, J23100 and J23106 from our last batch of PCR amplificates. Besides J23100 from today's PCR all BioBricks showed bands of the expected size that were isolated via gel extraction. | A gel electrophoresis was conducted with the freshly acquired PCR products of B0015, J23100 and J23106 as well as C0060, C0061, C0070, J23100 and J23106 from our last batch of PCR amplificates. Besides J23100 from today's PCR all BioBricks showed bands of the expected size that were isolated via gel extraction. | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, June 6, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, June 6, 2013</p> | ||
Line 219: | Line 252: | ||
In order to obtain the inserts a gel electrophoresis was conducted and the appropriate band was isolated by gel extraction. The ligations were conducted according to the following table. | In order to obtain the inserts a gel electrophoresis was conducted and the appropriate band was isolated by gel extraction. The ligations were conducted according to the following table. | ||
<img alt="June6" src="https://static.igem.org/mediawiki/2013/f/fd/Braunschweig_Lab_Journal_June_6.png" width="600" align="center" vspace="0" hspace="20"/></p> | <img alt="June6" src="https://static.igem.org/mediawiki/2013/f/fd/Braunschweig_Lab_Journal_June_6.png" width="600" align="center" vspace="0" hspace="20"/></p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Friday, June 7, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Friday, June 7, 2013</p> | ||
Line 235: | Line 271: | ||
<p style=" margin-left:5px; margin-right:5px;">This week we confirmed the successful cloning of the constitutive promoter + RBS. Furthermore we confirmed the addition of the double terminator to the autoinducer synthases and the lactonase. More BioBrick sequences were verified. However, we observed some point mutations in the prefix/suffix sequences of some bricks as well as major annotation differences in the BioBrick C0061. | <p style=" margin-left:5px; margin-right:5px;">This week we confirmed the successful cloning of the constitutive promoter + RBS. Furthermore we confirmed the addition of the double terminator to the autoinducer synthases and the lactonase. More BioBrick sequences were verified. However, we observed some point mutations in the prefix/suffix sequences of some bricks as well as major annotation differences in the BioBrick C0061. | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Sunday, June 9, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Sunday, June 9, 2013</p> | ||
Line 242: | Line 281: | ||
We ran a colony PCR of two clones of each ligation (transformation from June 6, 2013) and the biobricks P1002 and K091117 (primers VF2 and VR).<br> | We ran a colony PCR of two clones of each ligation (transformation from June 6, 2013) and the biobricks P1002 and K091117 (primers VF2 and VR).<br> | ||
We also inoculated overnight cultures for plasmid preparations the next day.</p> | We also inoculated overnight cultures for plasmid preparations the next day.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, June 10, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, June 10, 2013</p> | ||
Line 250: | Line 292: | ||
<img alt="June10" src="https://static.igem.org/mediawiki/2013/5/50/Braunschweig_Lab_Journal_June_10.png" width="600" align="center" vspace="0" hspace="10"/><br><br> | <img alt="June10" src="https://static.igem.org/mediawiki/2013/5/50/Braunschweig_Lab_Journal_June_10.png" width="600" align="center" vspace="0" hspace="10"/><br><br> | ||
We isolated the plasmid DNA from all clones with a miniprep kit following the manufacturer’s instructions.</p> | We isolated the plasmid DNA from all clones with a miniprep kit following the manufacturer’s instructions.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, June 11, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, June 11, 2013</p> | ||
Line 261: | Line 306: | ||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, June 12, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, June 12, 2013</p> | ||
Line 271: | Line 317: | ||
The remaining DNA sequences (from June 7,2013) were analyzed by sequence alignment. While the BioBricks J06702, B0012, C0071, R0062 and R0071 were sequence verified, the BioBrick C0062 did not match the sequence, the DNA sequencing for clone 2 failed. Furthermore the sequence alignment of E0240 revealed additional 25 bp after the EcoRI restriction site. The DNA sequence of E0430 was confirmed except for a point mutation (T to A between Not/I and XbaI restriction site) as well as the BioBrick J23112 which contained a point mutation in the prefix sequence (T to A). | The remaining DNA sequences (from June 7,2013) were analyzed by sequence alignment. While the BioBricks J06702, B0012, C0071, R0062 and R0071 were sequence verified, the BioBrick C0062 did not match the sequence, the DNA sequencing for clone 2 failed. Furthermore the sequence alignment of E0240 revealed additional 25 bp after the EcoRI restriction site. The DNA sequence of E0430 was confirmed except for a point mutation (T to A between Not/I and XbaI restriction site) as well as the BioBrick J23112 which contained a point mutation in the prefix sequence (T to A). | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, June 13, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, June 13, 2013</p> | ||
Line 284: | Line 333: | ||
For C0061, the restriction failed. The size of the linearized vector is about 10kb confirming differences in the Registry of Standard Parts annotation and the BioBrick.<br> | For C0061, the restriction failed. The size of the linearized vector is about 10kb confirming differences in the Registry of Standard Parts annotation and the BioBrick.<br> | ||
The sequence data from June 11, 2013 was analyzed by sequence alignments. J23100+B0032 and J23105+B0032 did not contain the promoters. J23112+B0032, C0078+B0015, C0070+B0015, C0060+B0015 was sequence verified. Unfortunately the sequencing failed for K091117 and P1002.</p> | The sequence data from June 11, 2013 was analyzed by sequence alignments. J23100+B0032 and J23105+B0032 did not contain the promoters. J23112+B0032, C0078+B0015, C0070+B0015, C0060+B0015 was sequence verified. Unfortunately the sequencing failed for K091117 and P1002.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Friday, June 14, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Friday, June 14, 2013</p> | ||
Line 299: | Line 351: | ||
<p style=" margin-left:5px; margin-right:5px;">This week was dominated by a lot of cloning. We equipped our constitutive and inducible promoters with ribosome binding sites, terminators, an Ampicillin resistance gene and a lactonase (not all of them got each of these elements). Additionally, we separated the Ampicillin resistance gene from its native promoter in order to make its expression inducible. Although cloning was mostly successful, we were struggling to amplify and purified the <i>luxR</i> brick (C0062), which cost us a lot of time and effort. Unfortunately, it also wasn’t rewarded with success in the end.<br> | <p style=" margin-left:5px; margin-right:5px;">This week was dominated by a lot of cloning. We equipped our constitutive and inducible promoters with ribosome binding sites, terminators, an Ampicillin resistance gene and a lactonase (not all of them got each of these elements). Additionally, we separated the Ampicillin resistance gene from its native promoter in order to make its expression inducible. Although cloning was mostly successful, we were struggling to amplify and purified the <i>luxR</i> brick (C0062), which cost us a lot of time and effort. Unfortunately, it also wasn’t rewarded with success in the end.<br> | ||
Another important step was to adapt our cloning strategy towards new chromoproteins which we received from iGEM team Uppsala. These allow us to evaluate our cultivation experiments solely with own equipment, rather than having to find a cell sorter with suitable excitement lasers for all fluorescent proteins.</p> | Another important step was to adapt our cloning strategy towards new chromoproteins which we received from iGEM team Uppsala. These allow us to evaluate our cultivation experiments solely with own equipment, rather than having to find a cell sorter with suitable excitement lasers for all fluorescent proteins.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, June 17, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, June 17, 2013</p> | ||
Line 306: | Line 361: | ||
Today, we digested the inducible promoters, followed by purification and clean-up. Then we equipped the inducible and previously digested constitutive promoters with a RBS (B0032) by ligating respective parts. Subsequently, these ligated constructs were used to transform competent bacteria. | Today, we digested the inducible promoters, followed by purification and clean-up. Then we equipped the inducible and previously digested constitutive promoters with a RBS (B0032) by ligating respective parts. Subsequently, these ligated constructs were used to transform competent bacteria. | ||
We also inoculated overnight suspension cultures with B0015- and B0032-transformed <i>E. coli</i> cells from cryo stocks for DNA preparation.</p> | We also inoculated overnight suspension cultures with B0015- and B0032-transformed <i>E. coli</i> cells from cryo stocks for DNA preparation.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, June 18, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, June 18, 2013</p> | ||
Line 312: | Line 370: | ||
We performed a colony PCR to test if cloning from the previous day was successful. Positively tested clones were used to inoculate suspension cultures for DNA preparation. Overnight suspension cultures of B0015- and B0032-transformed cells were used for DNA preparation.<br> | We performed a colony PCR to test if cloning from the previous day was successful. Positively tested clones were used to inoculate suspension cultures for DNA preparation. Overnight suspension cultures of B0015- and B0032-transformed cells were used for DNA preparation.<br> | ||
In order to separate the Ampicillin resistance gene from its native promoter we performed a Phusion-PCR with appropriate primers on the P1002 brick.</p> | In order to separate the Ampicillin resistance gene from its native promoter we performed a Phusion-PCR with appropriate primers on the P1002 brick.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, June 19, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, June 19, 2013</p> | ||
Line 320: | Line 381: | ||
After the second colony PCR was also found to be negative, these parts were once again digested, including gel extraction and purification. Furthermore, the previously amplified <i>ampR</i> gene was purified by gel electrophoresis. However, gel extraction did not yield enough DNA to work with. | After the second colony PCR was also found to be negative, these parts were once again digested, including gel extraction and purification. Furthermore, the previously amplified <i>ampR</i> gene was purified by gel electrophoresis. However, gel extraction did not yield enough DNA to work with. | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, June 20, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, June 20, 2013</p> | ||
Line 335: | Line 399: | ||
We also changed our cloning strategy as we thankfully received new chromoproteins from iGEM team Uppsala. | We also changed our cloning strategy as we thankfully received new chromoproteins from iGEM team Uppsala. | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Saturday, June 22, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Saturday, June 22, 2013</p> | ||
Line 356: | Line 423: | ||
Good news is that we received the chromoproteins from Uppsala! So we started working on our new cloning strategy by combining the chromoprotein DNA with our constitutive promotor-RBS construct. We hope to see nice and colorful colonies next week! | Good news is that we received the chromoproteins from Uppsala! So we started working on our new cloning strategy by combining the chromoprotein DNA with our constitutive promotor-RBS construct. We hope to see nice and colorful colonies next week! | ||
</p> | </p> | ||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
Line 362: | Line 431: | ||
<b>Investigators: Roman, Laura </b><br> | <b>Investigators: Roman, Laura </b><br> | ||
<img alt="July1" src="https://static.igem.org/mediawiki/2013/9/9f/Braunschweig_Lab_Journal_July_1.png" width="200" align="right" vspace="0" hspace="10"/>In order to combine lactonase and our lactonase-terminator construct as well as LasI und the LasI-terminator construct with the ribosome binding site and a constitutive promotor we digested B0032, C0060, C0061-B0015, J23112-B0032 and C0060-B0015. Afterwards gel extraction was performed for the inserts C0060, C0061-B0015 and C0060-B0015 and DNA purification for the vectors. Inserts and vectors were ligated using T4-DNA Ligase (NEB) overnight at 16°C.</p> | <img alt="July1" src="https://static.igem.org/mediawiki/2013/9/9f/Braunschweig_Lab_Journal_July_1.png" width="200" align="right" vspace="0" hspace="10"/>In order to combine lactonase and our lactonase-terminator construct as well as LasI und the LasI-terminator construct with the ribosome binding site and a constitutive promotor we digested B0032, C0060, C0061-B0015, J23112-B0032 and C0060-B0015. Afterwards gel extraction was performed for the inserts C0060, C0061-B0015 and C0060-B0015 and DNA purification for the vectors. Inserts and vectors were ligated using T4-DNA Ligase (NEB) overnight at 16°C.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, July 2, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, July 2, 2013</p> | ||
Line 369: | Line 441: | ||
Since the chromoprotein DNA from Uppsala iGEM Team 2011 arrived today we now switched to our new cloning strategy starting with resuspending and transforming the newly arrived DNA into <i>E. coli</i> XL1 by heatshock. Cells were as well plated on 2xYT agar containing Glucose and Chloramphenicol.<br> | Since the chromoprotein DNA from Uppsala iGEM Team 2011 arrived today we now switched to our new cloning strategy starting with resuspending and transforming the newly arrived DNA into <i>E. coli</i> XL1 by heatshock. Cells were as well plated on 2xYT agar containing Glucose and Chloramphenicol.<br> | ||
Even if we switched to our new strategy we still kept working on the fluorescence markers. Therefore we digested the BioBricks E0420 (eCFP), E0430 (YFP) and J06702 (mCherry) as well as our promotor-RBS-LasR and promotor-RBS-RhlR-constructs. Still lacking the construct containing LuxR we decided to proceed with the promotor-RBS-construct instead to ligate it to the YFP-Brick. Gel extraction was performed for the inserts and DNA purification for the vector parts. Inserts and bricks were ligated overnight using T4 DNA ligase (NEB) at 16°C.<br><br> | Even if we switched to our new strategy we still kept working on the fluorescence markers. Therefore we digested the BioBricks E0420 (eCFP), E0430 (YFP) and J06702 (mCherry) as well as our promotor-RBS-LasR and promotor-RBS-RhlR-constructs. Still lacking the construct containing LuxR we decided to proceed with the promotor-RBS-construct instead to ligate it to the YFP-Brick. Gel extraction was performed for the inserts and DNA purification for the vector parts. Inserts and bricks were ligated overnight using T4 DNA ligase (NEB) at 16°C.<br><br> | ||
- | |||
Since we now have our first constructs containing the inducible promotors as well as the the Ampicillin resistence gen we started our first leakiness experiments. All constructs (P<sub>las</sub>, P<sub>rhl</sub>, P<sub>lux</sub> in combination with the RBS and <i>ampR</i>) were cultivated overnight in 2xYT medium containing various Ampicillin concentrations.</p> | Since we now have our first constructs containing the inducible promotors as well as the the Ampicillin resistence gen we started our first leakiness experiments. All constructs (P<sub>las</sub>, P<sub>rhl</sub>, P<sub>lux</sub> in combination with the RBS and <i>ampR</i>) were cultivated overnight in 2xYT medium containing various Ampicillin concentrations.</p> | ||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, July 3, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, July 3, 2013</p> | ||
Line 377: | Line 450: | ||
<b>Investigators: Kerstin, Laura </b><br> | <b>Investigators: Kerstin, Laura </b><br> | ||
Before we started working on our own chromoprotein-constructs, we screened for the optimum cultivation conditions. We cultivated <i>E. coli</i> XL1 containing a new construct from Uppsala iGEM containing the device J23110-B0034-aeBlue. We tested expression of the blue chromoprotein at different temperatures, oxygen supply and rpm. These experiments led to the conclusion that low oxygen supply and a temperature of 37°C result in higher expression rates.<br><br> | Before we started working on our own chromoprotein-constructs, we screened for the optimum cultivation conditions. We cultivated <i>E. coli</i> XL1 containing a new construct from Uppsala iGEM containing the device J23110-B0034-aeBlue. We tested expression of the blue chromoprotein at different temperatures, oxygen supply and rpm. These experiments led to the conclusion that low oxygen supply and a temperature of 37°C result in higher expression rates.<br><br> | ||
- | |||
The evaluation of the leakiness of the inducible promotors showed that only the P<sub>rhl</sub> is not leaky. P<sub>lux</sub> as well as P<sub>las</sub> were leaky and showed growth of <i>E. coli</i> XL1 at all tested Ampicillin concentrations. Therefore we repeated the experiment using higher Ampicillin conentrations.<br><br> | The evaluation of the leakiness of the inducible promotors showed that only the P<sub>rhl</sub> is not leaky. P<sub>lux</sub> as well as P<sub>las</sub> were leaky and showed growth of <i>E. coli</i> XL1 at all tested Ampicillin concentrations. Therefore we repeated the experiment using higher Ampicillin conentrations.<br><br> | ||
- | |||
The bricks containing the fluorescencw markers ligated yesterday were transformed in <i>E. coli</i> XL1 by heatshock.<br><br> | The bricks containing the fluorescencw markers ligated yesterday were transformed in <i>E. coli</i> XL1 by heatshock.<br><br> | ||
- | |||
<img alt="July3" src="https://static.igem.org/mediawiki/2013/f/fa/Braunschweig_Lab_Journal_July_3.png" width="200" align="right" vspace="0" hspace="10"/>Colony PCR of the constructs containing lactonase and LuxI which were transformed yesterday was performed. Since all screened colonies showed religated vectors we decided to try an alternative restriction strategy to combine the BioBricks by using the endonuclease NcoI.<br> | <img alt="July3" src="https://static.igem.org/mediawiki/2013/f/fa/Braunschweig_Lab_Journal_July_3.png" width="200" align="right" vspace="0" hspace="10"/>Colony PCR of the constructs containing lactonase and LuxI which were transformed yesterday was performed. Since all screened colonies showed religated vectors we decided to try an alternative restriction strategy to combine the BioBricks by using the endonuclease NcoI.<br> | ||
B0032, C0060 and C0061-B0015 were digested with NcoI and corresponding SpeI and XbaI. Gel extraction was performed for the vector DNA as well as the inserts.<br> | B0032, C0060 and C0061-B0015 were digested with NcoI and corresponding SpeI and XbaI. Gel extraction was performed for the vector DNA as well as the inserts.<br> | ||
Overnight liquid cultures were inoculated with <i>E. coli</i> XL1 containing the chromoprotein in 2xYT supplemented with Chloramphenicol.</p> | Overnight liquid cultures were inoculated with <i>E. coli</i> XL1 containing the chromoprotein in 2xYT supplemented with Chloramphenicol.</p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, July 4, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, July 4, 2013</p> | ||
Line 392: | Line 465: | ||
Ligation of the constructs B0032-C0060 (containing lactonase) and B0032-C0061-B0015 (containing LuxI) was performed for 30 minutes at room temperature using T4 DNA Ligase (NEB). Constructs were transformed in <i>E. coli</i> XL1 by heatshock and plated on agar plates.<br> | Ligation of the constructs B0032-C0060 (containing lactonase) and B0032-C0061-B0015 (containing LuxI) was performed for 30 minutes at room temperature using T4 DNA Ligase (NEB). Constructs were transformed in <i>E. coli</i> XL1 by heatshock and plated on agar plates.<br> | ||
As we were still having trouble with the brick C0062 (LuxR) we amplified the brick from the device F2620 using Q5 Polymerase (NEB). Gelextraction was performed for the PCR products.<br><br><br><br><br> | As we were still having trouble with the brick C0062 (LuxR) we amplified the brick from the device F2620 using Q5 Polymerase (NEB). Gelextraction was performed for the PCR products.<br><br><br><br><br> | ||
- | |||
<img alt="July4_2" src="https://static.igem.org/mediawiki/2013/b/b4/Braunschweig_Lab_Journal_July_4_2.png" width="150" align="right" vspace="0" hspace="10"/>The chromoprotein cultures were miniprepped and DNA was directly used for digestion to combine the chromoproteins with our promotor-RBS construct. The insert parts were extracted from an agarose gel while the vector part was dephosphorylated and purified using DNA clean-up columns.<br> | <img alt="July4_2" src="https://static.igem.org/mediawiki/2013/b/b4/Braunschweig_Lab_Journal_July_4_2.png" width="150" align="right" vspace="0" hspace="10"/>The chromoprotein cultures were miniprepped and DNA was directly used for digestion to combine the chromoproteins with our promotor-RBS construct. The insert parts were extracted from an agarose gel while the vector part was dephosphorylated and purified using DNA clean-up columns.<br> | ||
Colony PCR was conducted for the constructs with the fluorescent proteins which were transformed yesterday. We were able to identify colonies with the right construct size for all tested constructs.</p> | Colony PCR was conducted for the constructs with the fluorescent proteins which were transformed yesterday. We were able to identify colonies with the right construct size for all tested constructs.</p> | ||
+ | |||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Friday, July 5, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Friday, July 5, 2013</p> | ||
Line 439: | Line 515: | ||
<p style=" margin-left:5px; margin-right:5px;"> | <p style=" margin-left:5px; margin-right:5px;"> | ||
This week was dominated by testing our constructs in continuous as well as in batch culture for inducibility and regulation. Unregulated growth in chloramphenicol containing medium and regulated growth in ampicillin containing medium was tested in continuous culture. The growth kinetics observed for our Rhl regulated could be verified in a second growth curve for induced and uninduced growth. Further we received <i>E. coli</i> JM109 strains containing a reporter plasmid expressing <i>luxCDABE</i> in the presence of specific activating N-acyl homoserine lactones (AHLs) (Winsen, M.K. et al. 1998) resulting in bioluminescence of these reporter strains. We will be using these strains in order to verify the production of the specific homoserine lactones by our constructs.<br> </p> | This week was dominated by testing our constructs in continuous as well as in batch culture for inducibility and regulation. Unregulated growth in chloramphenicol containing medium and regulated growth in ampicillin containing medium was tested in continuous culture. The growth kinetics observed for our Rhl regulated could be verified in a second growth curve for induced and uninduced growth. Further we received <i>E. coli</i> JM109 strains containing a reporter plasmid expressing <i>luxCDABE</i> in the presence of specific activating N-acyl homoserine lactones (AHLs) (Winsen, M.K. et al. 1998) resulting in bioluminescence of these reporter strains. We will be using these strains in order to verify the production of the specific homoserine lactones by our constructs.<br> </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Sunday, August 11, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Sunday, August 11, 2013</p> | ||
Line 444: | Line 523: | ||
<b>Investigators: Roman </b><br> | <b>Investigators: Roman </b><br> | ||
We prepared pre-cultures of our chromoprotein expression cassettes (promoter-RBS-chromoprotein) in E. coli XL1. For each chromoprotein (amilGFP, eforRed, aeBlue) 50 ml 2xYT containing chloramphenicol were inoculated from -80°C glycerol stocks and grown at 37°C and 250 rpm over night.<br></p> | We prepared pre-cultures of our chromoprotein expression cassettes (promoter-RBS-chromoprotein) in E. coli XL1. For each chromoprotein (amilGFP, eforRed, aeBlue) 50 ml 2xYT containing chloramphenicol were inoculated from -80°C glycerol stocks and grown at 37°C and 250 rpm over night.<br></p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, August 12, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Monday, August 12, 2013</p> | ||
Line 453: | Line 535: | ||
A continuous cultivation of the Rhl inducible construct in E. coli Top 10 prepared, including preparation of pre-cultures of our inducible construct in 50 ml 2xYT containing chloramphenicol and grown at 37°C and 250 rpm over night.<br> | A continuous cultivation of the Rhl inducible construct in E. coli Top 10 prepared, including preparation of pre-cultures of our inducible construct in 50 ml 2xYT containing chloramphenicol and grown at 37°C and 250 rpm over night.<br> | ||
</p> | </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, August 13, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Tuesday, August 13, 2013</p> | ||
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | <p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | ||
- | <b>Investigators: Kevin, Melanie </b><br> | + | <b>Investigators: Kevin, Melanie, Judith, Jan, Roman </b><br> |
Unfortunately, the agar plates from yesterday’s mixed culture didn’t show any colour which might be due to contamination. Therefore we did not evaluate these plates any further. We also had some problems with the shaker and lost the culture containing the aeBlue construct. A test was run on how to dilute a mixed culture of the remaining eforRed and amilGFP constructs in order to be able to count colonies of each colour on large agar plates.<br> | Unfortunately, the agar plates from yesterday’s mixed culture didn’t show any colour which might be due to contamination. Therefore we did not evaluate these plates any further. We also had some problems with the shaker and lost the culture containing the aeBlue construct. A test was run on how to dilute a mixed culture of the remaining eforRed and amilGFP constructs in order to be able to count colonies of each colour on large agar plates.<br> | ||
Line 462: | Line 547: | ||
The first continuous cultivations were carried out in order to get to know the routines and problems of a continuous cultivation. Due to problems with the regulation of pumps no valuable results were produced but the setting was improved based on these experiences.<br></p> | The first continuous cultivations were carried out in order to get to know the routines and problems of a continuous cultivation. Due to problems with the regulation of pumps no valuable results were produced but the setting was improved based on these experiences.<br></p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, August 14, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Wednesday, August 14, 2013</p> | ||
Line 472: | Line 560: | ||
Pre-cultures of <i>E. coli</i> Top10F’ containing final P<sub>Rhl</sub> inducible construct and <i>E. coli</i> XL1 containing final P<sub>Las</sub> inducible construct in 50 ml 2xYT containing chloramphenicol for continuous cultures were grown at 37°C and 250 rpm overnight.<br></p> | Pre-cultures of <i>E. coli</i> Top10F’ containing final P<sub>Rhl</sub> inducible construct and <i>E. coli</i> XL1 containing final P<sub>Las</sub> inducible construct in 50 ml 2xYT containing chloramphenicol for continuous cultures were grown at 37°C and 250 rpm overnight.<br></p> | ||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, August 15, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, August 15, 2013</p> | ||
<p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | <p style="margin-left:5px; margin-right:5px; margin-bottom:0px; margin-top:0px"> | ||
- | <b>Investigators: Laura, Kerstin, Roman, Kevin, Jan </b><br> | + | <b>Investigators: Laura, Kerstin, Roman, Kevin, Jan, Judith </b><br> |
Pre-culture of erforRed expression cassette in <i>E. coli</i> Top10F’ in 50 ml 2xYT containing Chloramphenicol was inoculated from the agar plate and grown at 37°C and 250 rpm overnight.<br> | Pre-culture of erforRed expression cassette in <i>E. coli</i> Top10F’ in 50 ml 2xYT containing Chloramphenicol was inoculated from the agar plate and grown at 37°C and 250 rpm overnight.<br> | ||
Line 485: | Line 575: | ||
The first attempt to cultivate regulated and unregulated mixed cultures in continuous culture was made today. For regulated growth Ampicllin was added to the medium, for unregulated growth Chloramphenicol was used as selection marker. Samples o9f each culture were taken at several time points. OD<sub>520</sub> was measured and dilutions of samples were plated on 2xYT agar plates containing Chloramphenicol. | The first attempt to cultivate regulated and unregulated mixed cultures in continuous culture was made today. For regulated growth Ampicllin was added to the medium, for unregulated growth Chloramphenicol was used as selection marker. Samples o9f each culture were taken at several time points. OD<sub>520</sub> was measured and dilutions of samples were plated on 2xYT agar plates containing Chloramphenicol. | ||
We had problems to find the right dilution of the agar plates (too many or too little colonies on plates). The results of these cultivations were therefore not statistically relevant and no conclusions about the regulation of growth by our constructs could be drawn.<br> </p> | We had problems to find the right dilution of the agar plates (too many or too little colonies on plates). The results of these cultivations were therefore not statistically relevant and no conclusions about the regulation of growth by our constructs could be drawn.<br> </p> | ||
+ | |||
+ | |||
+ | <p><img alt="grey line" src="https://static.igem.org/mediawiki/2013/4/4c/Braunschweig_grey_line.png" width="850" height="1" vspace="20"/></p> | ||
<p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, August 15, 2013</p> | <p style="font-size:14px; font-weight:bold; text-decoration:none; border:none; color:#be1e3c; margin-left:5px; margin-right:5px; margin-top:0px; margin-bottom:0px">Thursday, August 15, 2013</p> |
Revision as of 14:07, 2 October 2013
Labjournal
This is the documentation of our lab work. An overview on how we approached this project can be found under Approach. For detailed protocols of certain procedures please refer to Protocols. Attributions are given for each day, however please check our Attributions section for efforts beyond the lab work.
Our sponsors